SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694187-20-000070
Filing Date
2020-05-06
Accepted
2020-05-06 21:08:37
Documents
1
Period of Report
2020-05-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158881369954858.html 4  
1 FORM 4 wf-form4_158881369954858.xml 4 11440
  Complete submission text file 0001694187-20-000070.txt   12883
Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38551 | Film No.: 20854251

Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Issuer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences